Video Experimental Relacionado
Updated: Jun 4, 2026
06:27
Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
La única fibrilla triangular β-amiloide del Alzheimer tiene una cavidad a lo largo del eje de la fibrilla bajo
Yifat Miller1, Buyong Ma, Ruth Nussinov
1Center for Cancer Research Nanobiology Program NCI-Frederick, Frederick, Maryland 21702, USA.
Journal of the American Chemical Society
|February 9, 2011
Resumen
La investigación de la enfermedad de Alzheimer revela la estructura de las fibrillas Aβ1-40, identificando una cavidad central y las interacciones M35 a lo largo del eje de las fibrillas, cruciales para el diseño terapéutico.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- La neurociencia es la neurociencia.
- Biología Estructural Biología estructural.
Sus antecedentes:
- La investigación de la enfermedad de Alzheimer (EA) se centra en las fibrillas amiloide-beta (Aβ).
- La comprensión de la estructura de las fibrillas Aβ1-40) es clave para el desarrollo de terapias en etapa temprana.
- La metionina 35 (M35) es un residuo crítico debido a su potencial de oxidación e interacciones dentro de las fibrillas Aβ.
Objetivo del estudio:
- Para investigar los conformadores simétricos triples de las fibrillas Aβ de longitud completa.
- Para aclarar el papel de las interacciones de M35 en la estructura de las fibrillas Aβ.
- Para aclarar la base estructural para la formación de fibrillas Aβ{1-40) y la posible orientación terapéutica.
Principales métodos:
- Simulaciones de dinámica molecular de todos los átomos en disolvente explícito.
- Análisis de los datos experimentales de RMN en estado sólido (RMNSS).
- Interpretación estructural de las distancias entre residuos (M35-M35, I31-V39).
Principales resultados:
- Las simulaciones reproducen las distancias experimentales M35-M35 e I31-V39.
- Las interacciones M35-M35 ocurren principalmente a lo largo del eje fibril, no a través de él (>15 Å).
- Las fibrillas Aβ1-40) exhiben una estructura triangular con una gran cavidad axial y estabilizan las interacciones de los N-terminales.
Conclusiones:
- La estructura de las fibrillas Aβ1-40) presenta una cavidad axial, distinta de los modelos anteriores.
- Las interacciones de M35 a lo largo del eje de las fibrillas son significativas para la estabilidad de las fibrillas.
- La cavidad identificada en los oligómeros Aβ ((1-40/1-42) es relevante para la comprensión y la orientación de la toxicidad oligomérica en la enfermedad de Alzheimer.
Videos de Conceptos Relacionados
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Protein Folding
Overview
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...